COMP <GO>
CORZ vs MS // FORWARD P/E MULTIPLE
Core Scientific Inc. (NASDAQ) VS. Morgan Stanley (NYSE) • 15-METRIC TALLY: CORZ 1
— MS 12
▲ FORWARD P/E MULTIPLE LEADER: MS
LAST: $13.25 (-8.18%) • MKT CAP: $4.64B
forward-pe
29.0x
LAST: $184.30 (-3.00%) • MKT CAP: $298.41B
forward-pe
16.5x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CORZ VS. MS)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CORZ | MS | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 11.90% | 41.00% | -29.10 | MS | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | 3.00% | -38.00 | MS | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 31.0x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -9.72% | -7.25% | -2.47 | MS | /fcf-yield <GO> |
| Operating Margin | -60.00% | 24.60% | -84.60 | MS | /operating-margins <GO> |
| Net Profit Margin | -60.00% | 20.20% | -80.20 | MS | /net-margins <GO> |
| Revenue Growth (YoY) | -37.50% | 5.50% | -43.00 | MS | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.21% | -2.21 | MS | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.45 | 0.46 | -0.01 | MS | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 5/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 7.30% | 7.00% | +0.30 | MS | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 39.0 | 43.3 | -4.25 | MS | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.12 | 1.04 | +0.08 | CORZ | /macro-sensitivity <GO> |
| Forward P/E Multiple ACTIVE | 29.0x | 16.5x | +12.50 | MS | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $4.64B | $298.41B | -$293.77B | MS | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CORZ REV | MS REV | CORZ GROSS % | MS GROSS % | CORZ FCF | MS FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $319.0M | $0 | 11.9% | — | -$450.8M | -$17.89B |
| FY 2024 | $510.7M | $0 | 23.7% | — | -$52.1M | $1.36B |
| FY 2023 | $502.4M | $0 | 44.0% | — | $42.5M | -$33.54B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CORZ // BETA 1.12
MS // BETA 1.04